{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:14:54Z","timestamp":1792721694516,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ajo.2011.05.032","type":"journal-article","created":{"date-parts":[[2011,8,28]],"date-time":"2011-08-28T15:29:27Z","timestamp":1314545367000},"page":"1059-1066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["Beh\u00e7et Disease: Visual Prognosis and Factors Influencing the Development of Visual Loss"],"prefix":"10.1016","volume":"152","author":[{"given":"Simon R.J.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Menezo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Wakefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McCluskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Lightman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajo.2011.05.032_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.preteyeres.2007.09.002","article-title":"Beh\u00e7et's disease: ocular effects and treatment","volume":"27","author":"Deuter","year":"2008","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"10.1016\/j.ajo.2011.05.032_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.survophthal.2005.04.009","article-title":"Current concepts in the etiology and treatment of Beh\u00e7et disease","volume":"50","author":"Evereklioglu","year":"2005","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2011.05.032_bib3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Beh\u00e7et disease: an analysis of 880 patients","volume":"138","author":"Tugal-Tutkun","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2011.05.032_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0190-9622(99)70523-2","article-title":"Beh\u00e7et's disease and complex aphthosis","volume":"40","author":"Ghate","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.ajo.2011.05.032_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/sarh.2001.19819","article-title":"Treatment of Beh\u00e7et's disease\u2014an update","volume":"30","author":"Kaklamani","year":"2001","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.ajo.2011.05.032_bib6","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ajo.2008.06.019","article-title":"Ocular inflammation in Beh\u00e7et disease: incidence of ocular complications and of loss of visual acuity","volume":"146","author":"Kacmaz","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2011.05.032_bib7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/112067210801800410","article-title":"Ocular inflammatory signs observed in a cohort of Spanish patients with Beh\u00e7et disease and ocular inflammation","volume":"18","author":"Saenz-Frances","year":"2008","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2011.05.032_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00002281-199909000-00011","article-title":"Vasculopathy, Beh\u00e7et's syndrome, and familial Mediterranean fever","volume":"11","author":"Ozen","year":"1999","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.ajo.2011.05.032_bib9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-4362.2003.01741.x","article-title":"Evaluation of clinical findings according to sex in 2313 Turkish patients with Beh\u00e7et's disease","volume":"42","author":"Tursen","year":"2003","journal-title":"Int J Dermatol"},{"issue":"17","key":"10.1016\/j.ajo.2011.05.032_bib10","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u00e7et's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ajo.2011.05.032_bib11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bjo.70.8.589","article-title":"Treatment and visual prognosis in Beh\u00e7et's disease","volume":"70","author":"Ben-Ezra","year":"1986","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2011.05.032_bib12","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2165\/00003495-199142050-00006","article-title":"Practical treatment recommendations for pharmacotherapy of Beh\u00e7et's syndrome","volume":"42","author":"Yazici","year":"1991","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.ajo.2011.05.032_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0039-6257(82)90079-0","article-title":"Beh\u00e7et's disease","volume":"26","author":"Michelson","year":"1982","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2011.05.032_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0039-6257(01)00275-2","article-title":"Immunopathology of the noninfectious posterior and intermediate uveitides","volume":"46","author":"Boyd","year":"2001","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2011.05.032_bib15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0021-5155(99)00029-5","article-title":"Epidemiological features and visual prognosis of Beh\u00e7et's disease","volume":"43","author":"Ando","year":"1999","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2011.05.032_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/08830189709116845","article-title":"Uveitis in Beh\u00e7et's disease","volume":"14","author":"Nussenblatt","year":"1997","journal-title":"Int Rev Immunol"},{"issue":"2","key":"10.1016\/j.ajo.2011.05.032_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0161-6420(95)31022-6","article-title":"Prognostic factors of vision in patients with Beh\u00e7et disease","volume":"102","author":"Sakamoto","year":"1995","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2011.05.032_bib18","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/art.21231","article-title":"Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Beh\u00e7et's disease: an open-label trial","volume":"52","author":"Tugal-Tutkun","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.ajo.2011.05.032_bib19","first-page":"1362","article-title":"Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Beh\u00e7et's disease with refractory uveoretinitis","volume":"31","author":"Ohno","year":"2004","journal-title":"J Rheumatol"},{"issue":"8697","key":"10.1016\/j.ajo.2011.05.032_bib20","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et's disease","volume":"335","year":"1990","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ajo.2011.05.032_bib21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2011.05.032_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2011.05.032_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Beh\u00e7et's syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ajo.2011.05.032_bib24","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00417-005-0005-8","article-title":"Risk and prognostic factors of poor visual outcome in Beh\u00e7et's disease with ocular involvement","volume":"243","author":"Takeuchi","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2011.05.032_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1076\/ocii.10.1.53.10326","article-title":"Beh\u00e7et's disease in Western Switzerland: epidemiology and analysis of ocular involvement","volume":"10","author":"Ambresin","year":"2002","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.ajo.2011.05.032_bib26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF02169409","article-title":"Fundus changes associated with Beh\u00e7et's disease","volume":"227","author":"Atmaca","year":"1989","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2011.05.032_bib27","first-page":"339","article-title":"Beh\u00e7et's disease in Brazil\u2014a review of 49 cases with emphasis on ophthalmic manifestations","volume":"35","author":"Barra","year":"1991","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2011.05.032_bib28","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0161-6420(97)30249-8","article-title":"Risk factor assessment and prognosis of eye involvement in Beh\u00e7et's disease in Turkey","volume":"104","author":"Demiroglu","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2011.05.032_bib29","first-page":"225","article-title":"The eighth Frederick H","volume":"77","author":"Mishima","year":"1979","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"5","key":"10.1016\/j.ajo.2011.05.032_bib30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/112067210201200514","article-title":"Posterior segment involvement in ocular Beh\u00e7et's disease","volume":"12","author":"Ozdal","year":"2002","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2011.05.032_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00347-003-0927-7","article-title":"[Ocular involvement in Beh\u00e7et's disease: first 5-year-results for visual development after treatment with interferon alfa-2a]","volume":"101","author":"Deuter","year":"2004","journal-title":"Ophthalmologe"},{"issue":"5","key":"10.1016\/j.ajo.2011.05.032_bib32","first-page":"896","article-title":"Longterm visual prognosis of patients with ocular Adamantiades-Beh\u00e7et's disease treated with interferon-alpha-2a","volume":"35","author":"Krause","year":"2008","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.ajo.2011.05.032_bib33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.12968\/hmed.2008.69.10.31317","article-title":"Interferon-alpha in the management of patients with Beh\u00e7et's disease","volume":"69","author":"Yang","year":"2008","journal-title":"Br J Hosp Med (Lond)"},{"issue":"6","key":"10.1016\/j.ajo.2011.05.032_bib34","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ajo.2008.09.010","article-title":"Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Beh\u00e7et disease","volume":"146","author":"Tabbara","year":"2008","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939411004594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939411004594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:04:14Z","timestamp":1757595854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939411004594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0002939411004594"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2011.05.032","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13654956.15069056","asserted-by":"object"}]},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beh\u00e7et Disease: Visual Prognosis and Factors Influencing the Development of Visual Loss","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2011.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}